|
|
Volumn 97, Issue 5, 2006, Pages 1119-1120
|
|
Another year, another AUA
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALFUZOSIN;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
BICALUTAMIDE;
DARIFENACIN;
DOXAZOSIN;
DULOXETINE;
GOSERELIN;
LEUPRORELIN;
OXYBUTYNIN;
PENTOSAN POLYSULFATE;
PHOSPHODIESTERASE INHIBITOR;
SILDENAFIL;
SOLIFENACIN;
TACHYKININ RECEPTOR ANTAGONIST;
TADALAFIL;
TAMSULOSIN;
TOLTERODINE;
TROSPIUM CHLORIDE;
VARDENAFIL;
DRUG COST;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
ERECTILE DYSFUNCTION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INTERSTITIAL CYSTITIS;
MEDICAL ETHICS;
MEDICAL SOCIETY;
MEDICAL SPECIALIST;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATE HYPERTROPHY;
REVIEW;
RISK BENEFIT ANALYSIS;
STRESS INCONTINENCE;
XEROSTOMIA;
ADRENERGIC ALPHA-ANTAGONISTS;
DRUG INDUSTRY;
HUMANS;
IMPOTENCE;
MALE;
MARKETING;
PHOSPHODIESTERASE INHIBITORS;
PROSTATIC HYPERPLASIA;
|
|
EID: 33645745853
PISSN: 14644096
EISSN: 1464410X
Source Type: Journal
DOI: 10.1111/j.1464-410X.2006.06227.x Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|
